{"id":856,"date":"2026-08-09T05:21:00","date_gmt":"2026-08-09T04:21:00","guid":{"rendered":"https:\/\/peptidedeepdive.com\/?page_id=856"},"modified":"2026-09-22T14:25:52","modified_gmt":"2026-09-22T13:25:52","slug":"semax-selank","status":"publish","type":"page","link":"https:\/\/peptidedeepdive.com\/nl\/semax-selank\/","title":{"rendered":"Semax &amp; Selank: Evidence, Legal Status &amp; How They Compare"},"content":{"rendered":"\n<meta charset=\"utf-8\"\/>\n<meta content=\"width=device-width, initial-scale=1.0\" name=\"viewport\"\/>\n<title>Semax vs Selank: Evidence, Differences &amp; Legal Status (2026)<\/title>\n<meta content=\"Semax vs Selank compared: mechanisms, human evidence, a 52-person comparison study, FDA context and current UK\/EU legal status in 2026.\" name=\"description\"\/>\n<meta content=\"index,follow,max-image-preview:large,max-snippet:-1,max-video-preview:-1\" name=\"robots\"\/>\n<link href=\"https:\/\/peptidedeepdive.com\/semax-selank\/\" rel=\"canonical\"\/>\n<meta content=\"article\" property=\"og:type\"\/>\n<meta content=\"PeptideDeepDive\" property=\"og:site_name\"\/>\n<meta content=\"Semax vs Selank: Evidence, Differences &amp; Legal Status (2026)\" property=\"og:title\"\/>\n<meta content=\"Semax vs Selank compared: mechanisms, human evidence, a 52-person comparison study, FDA context and current UK\/EU legal status in 2026.\" property=\"og:description\"\/>\n<meta content=\"https:\/\/peptidedeepdive.com\/semax-selank\/\" property=\"og:url\"\/>\n<meta content=\"https:\/\/peptidedeepdive.com\/wp-content\/uploads\/2026\/08\/ChatGPT-Image-Aug-12-2026-07_46_16-PM.png\" property=\"og:image\"\/>\n<meta content=\"Two glass nasal spray bottles representing Semax and Selank in a dark laboratory-inspired scene\" property=\"og:image:alt\"\/>\n<meta content=\"2026-09-21T00:00:00+03:00\" property=\"article:modified_time\"\/>\n<meta content=\"summary_large_image\" name=\"twitter:card\"\/>\n<meta content=\"Semax vs Selank: Evidence, Differences &amp; Legal Status (2026)\" name=\"twitter:title\"\/>\n<meta content=\"Semax vs Selank compared: mechanisms, human evidence, a 52-person comparison study, FDA context and current UK\/EU legal status in 2026.\" name=\"twitter:description\"\/>\n<meta content=\"https:\/\/peptidedeepdive.com\/wp-content\/uploads\/2026\/08\/ChatGPT-Image-Aug-12-2026-07_46_16-PM.png\" name=\"twitter:image\"\/>\n<meta content=\"Two glass nasal spray bottles representing Semax and Selank in a dark laboratory-inspired scene\" name=\"twitter:image:alt\"\/>\n<link as=\"image\" fetchpriority=\"high\" href=\"https:\/\/peptidedeepdive.com\/wp-content\/uploads\/2026\/08\/ChatGPT-Image-Aug-12-2026-07_46_16-PM.png\" rel=\"preload\"\/>\n<link href=\"https:\/\/fonts.googleapis.com\" rel=\"preconnect\"\/>\n<link crossorigin=\"\" href=\"https:\/\/fonts.gstatic.com\" rel=\"preconnect\"\/>\n<link href=\"https:\/\/fonts.googleapis.com\/css2?family=IBM+Plex+Mono:wght@600&amp;display=swap\" rel=\"stylesheet\"\/>\n<style>\n  :root{\n    --black:#0B0D0C; --near-black:#111412; --white:#FFFFFF; --gray-bg:#F5F6F4; --line:#E4E6E1;\n    --text-soft:#6B6F6C; --emerald-bright:#92B9A4; --emerald-pale:#E9F1ED; --emerald-deep:#456C57;\n    --insert:#B65C42; --insert-bg:#F5E4DD; --max-w:760px;\n  }\n  *{box-sizing:border-box;}\n  html{scroll-behavior:smooth;}\n  body{margin:0; background:var(--white); color:var(--black); font-family:'Helvetica Neue', Helvetica, Arial, sans-serif; font-size:16px; line-height:1.65; -webkit-font-smoothing:antialiased;}\n  a{color:var(--emerald-deep);}\n  .wrap{max-width:var(--max-w); margin:0 auto; padding:0 24px;}\n  .mono{font-family:'IBM Plex Mono', monospace;}\n  .nav{position:sticky; top:0; z-index:40; background:rgba(11,13,12,0.95); backdrop-filter:blur(8px); border-bottom:1px solid rgba(255,255,255,0.08);}\n  .nav .wrap{max-width:1152px; display:flex; align-items:center; justify-content:space-between; padding:16px 24px;}\n  .brand{display:flex; align-items:center; gap:9px; color:#fff; font-weight:600; font-size:1.1rem; letter-spacing:-0.01em; text-decoration:none;}\n  .brand-logo{height:30px; width:30px; display:block; object-fit:contain; flex-shrink:0; background:transparent !important; border:0 !important; padding:0 !important; border-radius:0 !important; box-shadow:none !important;}\n  .nav-links{display:flex; gap:32px; font-size:14px; color:rgba(255,255,255,0.65);}\n  .nav-links a{text-decoration:none; color:inherit;}\n  .nav-links a:hover{color:#fff;}\n  @media (max-width:760px){ .nav-links{display:none;} }\n  .article-hero{padding:56px 0 8px;}\n  .breadcrumb{font-size:13px; color:var(--text-soft); margin-bottom:24px;}\n  .breadcrumb a{color:var(--text-soft); text-decoration:none;}\n  .breadcrumb a:hover{color:var(--emerald-deep);}\n  .r-badge{display:inline-flex; font-size:11px; font-weight:700; letter-spacing:0.05em; text-transform:uppercase; color:var(--emerald-deep); background:var(--emerald-pale); padding:5px 12px; border-radius:100px; margin-bottom:18px;}\n  h1{font-weight:600; letter-spacing:-0.02em; font-size:clamp(1.9rem,4.4vw,2.7rem); line-height:1.12; margin:0 0 18px;}\n  .dek{font-size:18px; color:var(--text-soft); max-width:62ch; margin:0 0 24px;}\n  .article-meta{display:flex; gap:14px; align-items:center; font-size:13px; color:var(--text-soft); font-weight:600; padding-bottom:32px; border-bottom:1px solid var(--line); margin-bottom:40px;}\n  .article-meta .dot{color:var(--line);}\n  .hero-image{width:100%; aspect-ratio:16\/9; margin:0 0 32px; overflow:hidden; border-radius:18px; background:var(--gray-bg);}\n  .hero-image img{display:block; width:100%; height:100%; object-fit:cover;}\n  article h2{font-size:1.5rem; font-weight:600; letter-spacing:-0.01em; margin:44px 0 16px;}\n  article h3{font-size:1.15rem; font-weight:600; letter-spacing:-0.01em; margin:32px 0 12px;}\n  article p{color:var(--text-soft); font-size:16.5px; line-height:1.75; margin:0 0 18px;}\n  article ul{color:var(--text-soft); font-size:16px; line-height:1.7; padding-left:22px; margin:0 0 20px;}\n  article li{margin-bottom:8px;}\n  article strong{color:var(--black); font-weight:600;}\n  .toc{background:var(--gray-bg); border:1px solid var(--line); border-radius:16px; padding:22px 26px; margin:32px 0 8px;}\n  .toc .label{font-size:11.5px; font-weight:700; letter-spacing:0.08em; text-transform:uppercase; color:var(--emerald-deep); margin-bottom:10px;}\n  .toc ul{margin:0; padding-left:18px; font-size:14.5px; color:var(--text-soft);}\n  .toc li{margin-bottom:6px;}\n  .toc a{color:var(--text-soft); text-decoration:none;}\n  .toc a:hover{color:var(--emerald-deep);}\n  .stat-row{display:grid; grid-template-columns:repeat(3,1fr); gap:14px; margin:28px 0 8px;}\n  .stat-box{background:var(--gray-bg); border:1px solid var(--line); border-radius:16px; padding:20px; text-align:center;}\n  .stat-box .num{font-family:'IBM Plex Mono', monospace; font-size:1.4rem; font-weight:600; color:var(--emerald-deep); margin-bottom:6px;}\n  .stat-box .label{font-size:12.5px; color:var(--text-soft); font-weight:600;}\n  @media (max-width:560px){ .stat-row{grid-template-columns:1fr;} }\n  .timeline{border-left:2px solid var(--line); margin:28px 0 8px; padding-left:0;}\n  .t-item{position:relative; padding:0 0 22px 26px;}\n  .t-item:last-child{padding-bottom:0;}\n  .t-item::before{content:\"\"; position:absolute; left:-7px; top:4px; width:12px; height:12px; border-radius:50%; background:var(--emerald-bright); border:2px solid #fff; outline:1px solid var(--emerald-deep);}\n  .t-date{font-family:'IBM Plex Mono', monospace; font-size:12.5px; color:var(--emerald-deep); font-weight:600; margin-bottom:4px;}\n  .t-item p{margin:0; font-size:14.5px;}\n  .callout{background:var(--black); color:#fff; border-radius:18px; padding:28px 30px; margin:36px 0;}\n  .callout .label{font-size:11.5px; font-weight:700; letter-spacing:0.08em; text-transform:uppercase; color:var(--emerald-bright); margin-bottom:12px;}\n  .callout p{color:rgba(255,255,255,0.7); margin:0 0 12px; font-size:15px;}\n  .callout p:last-child{margin-bottom:0;}\n  .callout strong{color:#fff;}\n  .country-grid{display:grid; grid-template-columns:1fr; gap:14px; margin:24px 0 8px;}\n  .country-card{border:1px solid var(--line); border-radius:16px; padding:20px 22px;}\n  .country-card .flag-label{display:flex; align-items:center; gap:10px; font-weight:600; font-size:15px; color:var(--black); margin-bottom:8px;}\n  .country-card .reg-body{font-family:'IBM Plex Mono', monospace; font-size:11px; color:var(--emerald-deep); background:var(--emerald-pale); padding:2px 9px; border-radius:100px; font-weight:600;}\n  .country-card p{margin:0; font-size:14.5px; color:var(--text-soft); line-height:1.65;}\n  .table-scroll{width:100%; overflow-x:auto; margin:24px 0 8px; -webkit-overflow-scrolling:touch;}\n  .compare-table{width:100%; min-width:620px; border-collapse:collapse; margin:0; font-size:14px;}\n  .compare-table th, .compare-table td{text-align:left; padding:12px 14px; border-bottom:1px solid var(--line); color:var(--text-soft); vertical-align:top;}\n  .compare-table th{color:var(--black); font-weight:600; font-size:12.5px; text-transform:uppercase; letter-spacing:0.03em; background:var(--gray-bg);}\n  .compare-table td strong{color:var(--black);}\n  .compare-table a{font-weight:600;}\n  @media (max-width:640px){ .compare-table{font-size:13px;} .compare-table th, .compare-table td{padding:10px;} }\n  .faq-item{border-bottom:1px solid var(--line); padding:18px 0;}\n  .faq-item:first-child{border-top:1px solid var(--line);}\n  .faq-item h3{margin:0 0 8px; font-size:16px;}\n  .faq-item p{margin:0; font-size:15px;}\n  .author-box{display:grid; grid-template-columns:auto 1fr; gap:16px; align-items:start; background:var(--gray-bg); border:1px solid var(--line); border-radius:16px; padding:20px 22px; margin:36px 0 8px;}\n  .author-mark{display:grid; place-items:center; width:42px; height:42px; border-radius:50%; background:var(--emerald-pale); color:var(--emerald-deep); font-family:'IBM Plex Mono', monospace; font-weight:600;}\n  .author-box strong{display:block; margin-bottom:5px;}\n  .author-box p{margin:0; font-size:14px; line-height:1.6;}\n  .refs{margin-top:60px; padding-top:32px; border-top:1px solid var(--line);}\n  .refs h3{font-size:1.15rem; font-weight:600; margin:0 0 18px;}\n  .refs ol{padding-left:20px; margin:0;}\n  .refs li{font-size:13px; color:var(--text-soft); line-height:1.6; margin-bottom:12px; word-break:break-word;}\n  .related-products{margin:48px 0 18px;}\n  .related-products-header{margin-bottom:18px;}\n  .related-products-header h2{font-size:1.35rem; margin:0 0 8px;}\n  .related-products-header p{color:var(--text-soft); font-size:14.5px; line-height:1.65; margin:0;}\n  .related-products-grid{display:grid; grid-template-columns:repeat(3,minmax(0,1fr)); gap:14px;}\n  .related-product-card{display:flex; flex-direction:column; min-width:0; overflow:hidden; background:#fff; border:1px solid var(--line); border-radius:16px;}\n  .related-product-image-wrap{aspect-ratio:1\/1; margin:7px 7px 0; overflow:hidden; background:#fff; border:1px solid var(--line); border-radius:12px;}\n  .related-product-image{display:block; width:100%; height:100%; object-fit:contain; border-radius:11px;}\n  .related-product-body{display:flex; flex-direction:column; flex:1; padding:15px;}\n  .related-product-tag{min-height:32px; color:var(--emerald-deep); font-size:10.5px; font-weight:700; letter-spacing:.05em; line-height:1.45; text-transform:uppercase;}\n  .related-product-card h3{min-height:45px; color:var(--black); font-size:1rem; line-height:1.35; margin:6px 0;}\n  .related-product-note{min-height:54px; color:var(--text-soft); font-size:12px; line-height:1.5; margin-bottom:9px;}\n  .related-product-price{color:var(--black); font-size:16px; font-weight:600; margin:0 0 12px;}\n  .related-product-actions{display:grid; gap:7px; margin-top:auto;}\n  .related-product-btn{display:flex; align-items:center; justify-content:center; min-height:42px; padding:10px 12px; border-radius:100px; font-size:12.5px; font-weight:600; line-height:1.2; text-align:center; text-decoration:none;}\n  .related-product-btn.primary{background:var(--black); color:#fff;}\n  .related-product-btn.primary:hover{background:var(--emerald-deep);}\n  .related-product-btn.secondary{background:#fff; color:var(--black); border:1px solid var(--line);}\n  .related-product-btn.secondary:hover{color:var(--emerald-deep); border-color:var(--emerald-deep);}\n  .related-products-disclosure{margin:13px 0 0; color:var(--text-soft); font-size:11.5px; line-height:1.55;}\n  @media (max-width:700px){\n    .related-products-grid{grid-template-columns:1fr;}\n    .related-product-card{display:grid; grid-template-columns:120px 1fr;}\n    .related-product-image-wrap{aspect-ratio:1\/1; margin:7px;}\n    .related-product-card h3,.related-product-tag,.related-product-note{min-height:0;}\n  }\n  @media (max-width:420px){\n    .related-product-card{display:flex;}\n    .related-product-image-wrap{aspect-ratio:16\/10;}\n  }\n  footer{background:var(--black); border-top:1px solid rgba(255,255,255,0.08);}\n  footer .wrap{max-width:1152px; display:flex; align-items:center; justify-content:space-between; flex-wrap:wrap; gap:20px; padding:40px 24px;}\n  footer p{color:rgba(255,255,255,0.35); font-size:12px; max-width:420px; text-align:right; margin:0;}\n  @media (max-width:640px){ footer .wrap{flex-direction:column; text-align:center;} footer p{text-align:center;} }\n\n  .compare-cta{margin:34px 0 42px;padding:22px;background:var(--gray-bg);border:1px solid var(--line);border-radius:18px}\n  .compare-cta .eyebrow{font-size:10.5px;font-weight:700;letter-spacing:.08em;text-transform:uppercase;color:var(--emerald-deep);margin-bottom:7px}\n  .compare-cta h2{font-size:1.2rem!important;margin:0 0 8px!important}\n  .compare-cta>p{font-size:13.5px!important;line-height:1.65!important;margin:0 0 14px!important}\n  .compare-cta-grid{display:grid;grid-template-columns:1fr 1fr;gap:12px}\n  .compare-cta-card{background:#fff;border:1px solid var(--line);border-radius:14px;padding:15px}\n  .compare-cta-card h3{font-size:15px!important;margin:0 0 4px!important}\n  .compare-cta-price{font-family:'IBM Plex Mono',monospace;font-size:12px;color:var(--black);font-weight:600;margin:0 0 9px}\n  .compare-cta-card p{font-size:12px!important;line-height:1.55!important;margin:0 0 10px!important}\n  .compare-cta-actions{display:grid;gap:7px}\n  .compare-cta-btn{display:flex;align-items:center;justify-content:center;min-height:38px;padding:8px 10px;border-radius:100px;text-decoration:none;font-size:11.5px;font-weight:700}\n  .compare-cta-btn.primary{background:var(--black);color:#fff!important}\n  .compare-cta-btn.secondary{background:#fff;color:var(--black)!important;border:1px solid var(--line)}\n  .compare-cta-note{font-size:10.8px!important;color:var(--text-soft)!important;line-height:1.55!important;margin:12px 0 0!important}\n  @media(max-width:620px){.compare-cta-grid{grid-template-columns:1fr}}\n  .related-products-grid.two-col{grid-template-columns:repeat(2,minmax(0,1fr))}\n  @media(max-width:700px){.related-products-grid.two-col{grid-template-columns:1fr}}\n\n\n  .compare-cta-image-wrap{\n    width:100%;\n    aspect-ratio:1\/1;\n    margin:0 0 12px;\n    overflow:hidden;\n    background:#fff;\n    border:1px solid var(--line);\n    border-radius:12px;\n  }\n  .compare-cta-image{\n    display:block;\n    width:100%;\n    height:100%;\n    object-fit:contain;\n  }\n<\/style>\n<script type=\"application\/ld+json\">\n{\"@context\":\"https:\/\/schema.org\",\"@type\":\"Article\",\"mainEntityOfPage\":{\"@type\":\"WebPage\",\"@id\":\"https:\/\/peptidedeepdive.com\/semax-selank\/\"},\"headline\":\"Semax vs Selank: Evidence, Differences & Legal Status (2026)\",\"description\":\"Semax vs Selank compared: mechanisms, human evidence, a 52-person comparison study, FDA context and current UK\/EU legal status in 2026.\",\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\/\/peptidedeepdive.com\/wp-content\/uploads\/2026\/08\/ChatGPT-Image-Aug-12-2026-07_46_16-PM.png\"},\"datePublished\":\"2026-08-12\",\"dateModified\":\"2026-09-21\",\"author\":{\"@type\":\"Organization\",\"name\":\"PeptideDeepDive Editorial Team\",\"url\":\"https:\/\/peptidedeepdive.com\/about\/\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"PeptideDeepDive\",\"url\":\"https:\/\/peptidedeepdive.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\/\/peptidedeepdive.com\/wp-content\/uploads\/2026\/07\/PeptideDeepDiveLogo-transparent.png\"}},\"about\":[{\"@type\":\"Thing\",\"name\":\"Semax\"},{\"@type\":\"Thing\",\"name\":\"Selank\"},{\"@type\":\"Thing\",\"name\":\"Medicines regulation in the United Kingdom and European Union\"}],\"isAccessibleForFree\":true,\"keywords\":[\"Semax vs Selank\",\"Semax and Selank\",\"Semax Selank comparison\",\"Semax human evidence\",\"Selank human evidence\",\"Semax Selank legal status UK EU\",\"Semax FDA 2026\"],\"citation\":[\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32342318\/\",\"https:\/\/pubmed.ncbi.nlm.nih.gov\/11517472\/\",\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18454096\/\",\"https:\/\/www.fda.gov\/media\/193348\/download\",\"https:\/\/www.fda.gov\/drugs\/human-drug-compounding\/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks\",\"https:\/\/www.gov.uk\/government\/publications\/supply-unlicensed-medicinal-products-specials\/supply-unlicensed-medicinal-products-specials\",\"https:\/\/eur-lex.europa.eu\/eli\/dir\/2001\/83\/2025-01-01\/eng\"]}\n<\/script>\n<script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@type\": \"BreadcrumbList\",\n  \"itemListElement\": [\n    {\"@type\": \"ListItem\", \"position\": 1, \"name\": \"Home\", \"item\": \"https:\/\/peptidedeepdive.com\/\"},\n    {\"@type\": \"ListItem\", \"position\": 2, \"name\": \"Research\", \"item\": \"https:\/\/peptidedeepdive.com\/research\/\"},\n    {\"@type\": \"ListItem\", \"position\": 3, \"name\": \"Semax vs Selank\", \"item\": \"https:\/\/peptidedeepdive.com\/semax-selank\/\"}\n  ]\n}\n<\/script>\n<script type=\"application\/ld+json\">\n{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the difference between Semax and Selank?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Semax is an ACTH(4-10)-derived peptide studied mainly in neurological and cognitive contexts, while Selank is a tuftsin-derived peptide studied mainly in anxiety-related and neuroimmune research. Their mechanisms and human evidence bases are not interchangeable.\"}},{\"@type\":\"Question\",\"name\":\"Have Semax and Selank been compared in the same human study?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes. A 2020 resting-state fMRI study included 52 healthy participants assigned to Semax, Selank or placebo groups and compared functional-connectivity changes. It was a comparison study, not a trial of the two peptides used together, and it did not establish clinical efficacy.\"}},{\"@type\":\"Question\",\"name\":\"Are Semax and Selank authorised medicines in the UK or EU?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Neither has a standard UK or EU marketing authorisation. Unlicensed-medicine, import, supply and possession rules are separate legal questions and can vary by jurisdiction; a research-use-only label does not create medicine approval.\"}},{\"@type\":\"Question\",\"name\":\"Did FDA approve Semax after its 2026 review?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. FDA's July 2026 Pharmacy Compounding Advisory Committee process concerned whether Semax-related bulk drug substances should be considered for the 503A Bulks List. That compounding-policy review is not FDA drug approval.\"}}]}\n<\/script>\n<div class=\"nav\">\n<div class=\"wrap\">\n<a aria-label=\"PeptideDeepDive home\" class=\"brand\" href=\"https:\/\/peptidedeepdive.com\/\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" alt=\"PeptideDeepDive logo\" class=\"brand-logo\" height=\"30\" src=\"https:\/\/i0.wp.com\/peptidedeepdive.com\/wp-content\/uploads\/2026\/07\/PeptideDeepDiveLogo-transparent.png?resize=30%2C30&#038;ssl=1\" width=\"30\"\/>PeptideDeepDive<\/a>\n<div class=\"nav-links\">\n<a href=\"https:\/\/peptidedeepdive.com\/shop\/\">Shop<\/a>\n<a href=\"https:\/\/peptidedeepdive.com\/research\/\">Research<\/a>\n<a href=\"https:\/\/peptidedeepdive.com\/peptide-coas\/\">\n        Lab Reports\n      <\/a>\n<a href=\"https:\/\/peptidedeepdive.com\/about\/\">About<\/a>\n<a href=\"https:\/\/peptidedeepdive.com\/faq\/\">FAQ<\/a>\n<a href=\"https:\/\/peptidedeepdive.com\/contact\/\">Contact<\/a>\n<\/div>\n<\/div>\n<\/div>\n<main class=\"wrap\">\n<div class=\"article-hero\">\n<div class=\"breadcrumb\"><a href=\"https:\/\/peptidedeepdive.com\/\">Home<\/a> \/ <a href=\"https:\/\/peptidedeepdive.com\/research\/\">Research<\/a> \/ Semax vs Selank<\/div>\n<span class=\"r-badge\">Guide \u00b7 Cognitive &amp; CNS<\/span>\n<h1>Semax vs Selank: Evidence, Differences &amp; Legal Status (2026)<\/h1>\n<p class=\"dek\">Semax and Selank are often grouped together as Russian-origin cognitive peptides, but they have different structures, research histories and proposed mechanisms. This guide compares the human evidence, a direct 52-person comparison study, 2026 FDA context and current UK\/EU medicine status.<\/p>\n<div class=\"article-meta\">\n<span>By PeptideDeepDive Editorial Team<\/span><span class=\"dot\">\u00b7<\/span><span>Reviewed 21 September 2026<\/span><span class=\"dot\">\u00b7<\/span><span>11 min read<\/span>\n<\/div>\n<\/div>\n<figure class=\"hero-image\">\n<img data-recalc-dims=\"1\" alt=\"Semax vs Selank Europe comparison shown as two glass nasal spray bottles\" decoding=\"async\" fetchpriority=\"high\" height=\"428\" loading=\"eager\" src=\"https:\/\/i0.wp.com\/peptidedeepdive.com\/wp-content\/uploads\/2026\/08\/ChatGPT-Image-Aug-12-2026-07_46_16-PM.png?resize=760%2C428&#038;ssl=1\" width=\"760\"\/>\n<\/figure>\n<div class=\"toc\">\n<div class=\"label\">In this guide<\/div>\n<ul>\n<li><a href=\"#short-answer\">The short answer<\/a><\/li>\n<li><a href=\"#semax-vs-selank\">Semax vs Selank: key differences<\/a><\/li>\n<li><a href=\"#how-they-work\">How researchers think Semax and Selank work<\/a><\/li>\n<li><a href=\"#evidence\">Human evidence and limitations<\/a><\/li>\n<li><a href=\"#direct-comparison\">52-person Semax vs Selank study<\/a><\/li>\n<li><a href=\"#fda-2026\">2026 FDA context<\/a><\/li>\n<li><a href=\"#eu-legal\">Are Semax and Selank legal in the UK and EU?<\/a><\/li>\n<li><a href=\"#compare\">How they compare with BPC-157 and TB-500<\/a><\/li>\n<li><a href=\"#products\">Related cognitive research listings<\/a><\/li>\n<li><a href=\"#faq\">FAQ<\/a><\/li>\n<\/ul>\n<\/div>\n<article>\n<h2 id=\"short-answer\">Semax vs Selank: the short answer<\/h2>\n<p><strong>Semax and Selank are separate heptapeptides with different research emphases.<\/strong> Semax is derived from ACTH(4\u201310) and has been studied mainly in neurological, cognitive and neuroprotective settings. Selank is derived from tuftsin and has been studied mainly in anxiety-related and neuroimmune settings.<\/p>\n<p>There is some human research for both compounds, including a 2020 study that compared Semax, Selank and placebo groups in 52 healthy participants. However, that study measured resting-state brain connectivity rather than clinical benefit, and it was <strong>not a trial of Semax and Selank used together<\/strong>. Neither compound has a standard UK or EU marketing authorisation.<\/p>\n<h2 id=\"semax-vs-selank\">Semax vs Selank: What Is the Difference?<\/h2>\n<p>The clearest Semax vs Selank difference lies in the research focus. Many sources group both compounds under the label \u201cRussian nootropic peptides.\u201d However, each has a different structure and research history. More importantly, current evidence does not support treating either one as an approved cognitive or anxiety medicine.<\/p>\n<div class=\"table-scroll\">\n<table class=\"compare-table\">\n<thead>\n<tr><th>Comparison point<\/th><th>Semax<\/th><th>Selank<\/th><\/tr>\n<\/thead>\n<tbody>\n<tr><td><strong>Peptide origin<\/strong><\/td><td>Synthetic analogue of ACTH(4\u201310)<\/td><td>Synthetic analogue derived from tuftsin<\/td><\/tr>\n<tr><td><strong>Main research focus<\/strong><\/td><td>Thinking, nerve protection and nerve-growth signals<\/td><td>Anxiety-linked pathways and immune signals<\/td><\/tr>\n<tr><td><strong>Proposed pathways<\/strong><\/td><td>BDNF\/TrkB and other nerve-growth signals, based largely on animal research<\/td><td>GABA, monoamine and immune-system signals<\/td><\/tr>\n<tr><td><strong>Human evidence<\/strong><\/td><td>Several small clinical or healthy-volunteer studies, largely from Russian research groups; limited independent replication<\/td><td>Small Russian clinical studies and healthy-volunteer research; limited independent replication<\/td><\/tr>\n<tr><td><strong>UK\/EU status<\/strong><\/td><td>No standard UK or EU marketing authorisation<\/td><td>No standard UK or EU marketing authorisation<\/td><\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2 id=\"how-they-work\">How Researchers Think Semax and Selank Work<\/h2>\n<p><strong>Semax:<\/strong> first, experimental studies link Semax to changes in brain-derived neurotrophic factor (BDNF) and TrkB signals. However, researchers carried out much of this work in animals. Therefore, those studies cannot prove a cognitive or clinical benefit in humans.<\/p>\n<p><strong>Selank:<\/strong> by contrast, laboratory papers and reviews discuss GABA receptors, monoamine pathways and immune signals. Researchers have also reported small human studies. Even so, the overall evidence falls far short of the large clinical programmes that Western regulators usually expect.<\/p>\n<h2 id=\"evidence\">Semax and Selank Human Evidence: What Is Actually Available?<\/h2>\n<p>Both peptides have published human research, so it is too broad to describe the evidence as purely animal or laboratory based. The bigger limitation is <strong>scale, replication and generalisability<\/strong>. Much of the literature comes from Russian research groups, some papers are available only in Russian, and the programmes are much smaller than the clinical-development packages normally used to support UK, EU or US marketing authorisation.<\/p>\n<p>For Semax, published clinical literature includes studies in neurological settings such as acute ischaemic stroke, alongside healthy-volunteer neuroimaging research. For Selank, a 2008 randomised study compared 30 patients receiving Selank with 32 receiving medazepam in people with generalised anxiety disorder or neurasthenia. These studies are relevant evidence, but they do not by themselves establish broad cognitive, anxiety or performance claims for modern online products.<\/p>\n<div class=\"stat-row\">\n<div class=\"stat-box\"><div class=\"num mono\">52<\/div><div class=\"label\">participants in a direct Semax\/Selank\/placebo fMRI study<\/div><\/div>\n<div class=\"stat-box\"><div class=\"num mono\">62<\/div><div class=\"label\">participants in a 2008 Selank vs medazepam study<\/div><\/div>\n<div class=\"stat-box\"><div class=\"num mono\">0<\/div><div class=\"label\">standard UK or EU marketing authorisations<\/div><\/div>\n<\/div>\n<h2 id=\"direct-comparison\">Was Semax vs Selank studied directly in humans?<\/h2>\n<p>Yes, but the result needs careful interpretation. A 2020 study by Panikratova and colleagues assessed resting-state functional connectivity in <strong>52 healthy participants<\/strong> receiving Semax, Selank or placebo. The investigators reported both shared and peptide-specific changes in connectivity involving the amygdala and temporal cortex.<\/p>\n<p>This is useful because both compounds were examined within one experimental framework. However, it was a short neuroimaging study, not a clinical trial showing that one peptide is better for cognition, anxiety or any disease. It also did <strong>not<\/strong> test a Semax + Selank combination.<\/p>\n<h2 id=\"fda-2026\">What changed with the FDA&#8217;s 2026 Semax review?<\/h2>\n<p>In July 2026, FDA&#8217;s Pharmacy Compounding Advisory Committee considered Semax free base and Semax acetate for possible inclusion on the 503A Bulks List. FDA evaluated nominated uses including cerebral ischaemia, migraine and trigeminal neuralgia and concluded that the available evidence was insufficient to support effectiveness for those uses. FDA also states that neither Semax form is a component of an FDA-approved drug.<\/p>\n<p>FDA&#8217;s current compounding-safety page separately flags both Semax and Selank acetate for potential immunogenicity concerns related to aggregation and peptide-related impurities, while noting important gaps in human safety information. <strong>Neither the Semax PCAC review nor a compounded-drug pathway is FDA drug approval.<\/strong><\/p>\n<aside aria-labelledby=\"semax-selank-research-listings\" class=\"compare-cta\">\n<div class=\"eyebrow\">Research listings after the evidence<\/div>\n<h2 id=\"semax-selank-research-listings\">Semax and Selank laboratory research listings<\/h2>\n<p>The two listings below are shown only after the human-evidence and FDA sections. Availability does not establish clinical effectiveness, medicine approval or equivalence to the preparations used in published studies.<\/p>\n<div class=\"compare-cta-grid\">\n<div class=\"compare-cta-card\"><div class=\"compare-cta-image-wrap\"><img data-recalc-dims=\"1\" alt=\"Semax 10mg and 30mg laboratory research product listing\" class=\"compare-cta-image\" decoding=\"async\" height=\"600\" loading=\"lazy\" src=\"https:\/\/i0.wp.com\/balticpeptides.com\/wp-content\/uploads\/2026\/07\/SEMAX10VIAL-1-300x300.png?resize=600%2C600&#038;ssl=1\" width=\"600\"\/><\/div>\n<h3>Semax (10mg \/ 30mg) \u2014 Vial \/ Nasal Spray<\/h3>\n<div class=\"compare-cta-price\">\u20ac34.99\u2013\u20ac59.99<\/div>\n<p>Laboratory research listing related to the Semax evidence reviewed above.<\/p>\n<div class=\"compare-cta-actions\">\n<a class=\"compare-cta-btn primary\" data-affiliate-link=\"\" data-position=\"mid-article\" data-product=\"semax\" href=\"https:\/\/balticpeptides.com\/product\/semax\/?sld=17\" rel=\"sponsored nofollow noopener\" target=\"_blank\">View Semax Listing<\/a>\n<a class=\"compare-cta-btn secondary\" href=\"https:\/\/peptidedeepdive.com\/semax\/\">Read Semax Guide<\/a>\n<\/div>\n<\/div>\n<div class=\"compare-cta-card\"><div class=\"compare-cta-image-wrap\"><img data-recalc-dims=\"1\" alt=\"Selank 10mg laboratory research product listing\" class=\"compare-cta-image\" decoding=\"async\" height=\"600\" loading=\"lazy\" src=\"https:\/\/i0.wp.com\/balticpeptides.com\/wp-content\/uploads\/2026\/07\/SELANK10VIAL-1-300x300.png?resize=600%2C600&#038;ssl=1\" width=\"600\"\/><\/div>\n<h3>Selank (10mg) \u2014 Vial \/ Nasal Spray<\/h3>\n<div class=\"compare-cta-price\">\u20ac34.99\u2013\u20ac39.99<\/div>\n<p>Laboratory research listing related to the Selank evidence reviewed above.<\/p>\n<div class=\"compare-cta-actions\">\n<a class=\"compare-cta-btn primary\" data-affiliate-link=\"\" data-position=\"mid-article\" data-product=\"selank\" href=\"https:\/\/balticpeptides.com\/product\/selank\/?sld=17\" rel=\"sponsored nofollow noopener\" target=\"_blank\">View Selank Listing<\/a>\n<a class=\"compare-cta-btn secondary\" href=\"https:\/\/peptidedeepdive.com\/selank\/\">Read Selank Guide<\/a>\n<\/div>\n<\/div>\n<\/div>\n<p class=\"compare-cta-note\"><strong>Affiliate disclosure:<\/strong> PeptideDeepDive may earn a commission from supplier links. Prices reflect supplier data checked on 18 September 2026 and may change. Laboratory research only; not recommendations for human use.<\/p>\n<\/aside>\n<h2 id=\"eu-legal\">Are Semax and Selank Legal in the UK, Ireland, Germany and EU?<\/h2>\n<p><strong>Neither compound has a standard marketing authorisation in the UK or EU.<\/strong> That is the clearest regulatory point. It does not automatically answer every question about possession, import, laboratory supply or exceptional clinical supply, because those issues depend on national law and how a product is presented and supplied. A \u201cresearch use only\u201d label also does not create medicine approval.<\/p>\n<div class=\"country-grid\">\n<div class=\"country-card\">\n<div class=\"flag-label\">\ud83c\uddec\ud83c\udde7 United Kingdom <span class=\"reg-body\">MHRA<\/span><\/div>\n<p>Unlicensed medicines do not have a UK marketing authorisation and may not have been assessed by the MHRA. UK law allows limited \u201cspecials\u201d supply where an authorised medicine cannot meet an individual patient&#8217;s clinical need, but that is different from ordinary consumer sale or advertising.<\/p>\n<\/div>\n<div class=\"country-card\">\n<div class=\"flag-label\">\ud83c\uddee\ud83c\uddea Ireland <span class=\"reg-body\">HPRA<\/span><\/div>\n<p>Medicines placed on the Irish market generally require HPRA or EU authorisation. Ireland also has an exempt-medicinal-product route for specific patients under a prescriber&#8217;s direct responsibility when an authorised medicine is not available.<\/p>\n<\/div>\n<div class=\"country-card\">\n<div class=\"flag-label\">\ud83c\udde9\ud83c\uddea Germany <span class=\"reg-body\">AMG<\/span><\/div>\n<p>Section 21 of Germany&#8217;s Medicinal Products Act generally requires finished medicines to have national or EU marketing authorisation before they are placed on the market, subject to defined statutory exceptions.<\/p>\n<\/div>\n<div class=\"country-card\">\n<div class=\"flag-label\">\ud83c\uddf3\ud83c\uddf1 Netherlands <span class=\"reg-body\">CBG-MEB \/ IGJ<\/span><\/div>\n<p>The Netherlands also provides controlled routes for some unlicensed products, including named-patient use. Those exceptional routes are not equivalent to a normal marketing authorisation or unrestricted retail supply.<\/p>\n<\/div>\n<\/div>\n<p>At EU level, Directive 2001\/83\/EC provides the general medicinal-product framework. The legal classification of a specific product can depend on its presentation, intended function and national implementation, so \u201cunapproved\u201d is more precise than a blanket claim that possession is universally legal or illegal across Europe.<\/p>\n<h2 id=\"compare\">Semax and Selank vs BPC-157 and TB-500: How They Compare<\/h2>\n<p>Semax vs Selank mainly compares two compounds from brain and nervous-system research. By contrast, researchers usually discuss BPC-157 and TB-500 in relation to tissue-repair models. Therefore, a comparison with those compounds crosses into a different research category.<\/p>\n<div class=\"table-scroll\">\n<table class=\"compare-table\">\n<thead>\n<tr><th>Peptide<\/th><th>Main research category<\/th><th>Human-evidence picture<\/th><th>UK\/EU status<\/th><\/tr>\n<\/thead>\n<tbody>\n<tr><td><strong>Semax<\/strong><\/td><td>Thinking and nerve protection<\/td><td>Russian research, including well-known animal studies; few independent teams have repeated the findings<\/td><td>No standard UK or EU marketing authorisation<\/td><\/tr>\n<tr><td><strong>Selank<\/strong><\/td><td>Anxiety-linked and immune signals<\/td><td>Small Russian human studies plus laboratory research; few independent teams have repeated the findings<\/td><td>No standard UK or EU marketing authorisation<\/td><\/tr>\n<tr><td><a href=\"https:\/\/peptidedeepdive.com\/bpc-157-legal\/\">BPC-157 legal status and human evidence<\/a><\/td><td>Tissue-repair models<\/td><td>Human evidence remains very limited<\/td><td>No standard UK or EU marketing authorisation<\/td><\/tr>\n<tr><td><a href=\"https:\/\/peptidedeepdive.com\/tb-500-legal\/\">TB-500 legal status and evidence<\/a><\/td><td>Soft-tissue-repair models<\/td><td>Some sources mix this evidence with thymosin beta-4 research; direct human evidence remains limited<\/td><td>No standard UK or EU marketing authorisation<\/td><\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>For the broader cluster, see our <a href=\"https:\/\/peptidedeepdive.com\/peptides-compared\/\">evidence-led comparison of seven peptide groups<\/a>. You can also read the individual <a href=\"https:\/\/peptidedeepdive.com\/semax\/\">Semax evidence guide<\/a> and <a href=\"https:\/\/peptidedeepdive.com\/selank\/\">Selank evidence guide<\/a>.<\/p>\n<div class=\"callout\">\n<div class=\"label\">The Key Distinction<\/div>\n<p>Overall, Semax and Selank&#8217;s Russian history creates a different evidence picture from BPC-157 and TB-500. However, that history does not create UK, Irish, German or EU approval. Likewise, calling a product a \u201cresearch chemical\u201d does not guarantee quality or settle whether its supply, import or marketing follows the law.<\/p>\n<\/div>\n<h2 id=\"faq\">Frequently Asked Questions<\/h2>\n<div class=\"faq-item\"><h3>What is the difference between Semax and Selank?<\/h3><p>Semax is an ACTH(4\u201310)-derived peptide studied mainly in neurological and cognitive contexts. Selank is a tuftsin-derived peptide studied mainly in anxiety-related and neuroimmune research. Their evidence bases and proposed mechanisms are not interchangeable.<\/p><\/div>\n<div class=\"faq-item\"><h3>Have Semax and Selank been compared in the same human study?<\/h3><p>Yes. A 2020 study included 52 healthy participants in separate Semax, Selank and placebo groups and assessed resting-state functional connectivity. It did not test the two peptides together and did not establish clinical efficacy.<\/p><\/div>\n<div class=\"faq-item\"><h3>Are Semax and Selank authorised medicines in the UK or EU?<\/h3><p>Neither has a standard UK or EU marketing authorisation. Unlicensed-medicine, import, supply and possession rules are separate legal questions and can vary by jurisdiction.<\/p><\/div>\n<div class=\"faq-item\"><h3>Did FDA approve Semax after its 2026 review?<\/h3><p>No. FDA&#8217;s July 2026 review concerned possible 503A Bulks List inclusion for Semax-related bulk drug substances. That compounding-policy process is not FDA approval of Semax as a drug.<\/p><\/div>\n<div class=\"author-box\">\n<div aria-hidden=\"true\" class=\"author-mark\">PD<\/div>\n<div><strong>About this guide<\/strong><p>The PeptideDeepDive Editorial Team wrote and checked this guide using regulator advice, official medicines-law sources and peer-reviewed research. In addition, the guide separates animal, laboratory and human evidence. Last evidence and legal-status review: 21 September 2026.<\/p><\/div>\n<\/div>\n<\/article>\n<section aria-labelledby=\"related-products-title\" class=\"related-products\" id=\"products\">\n<div class=\"related-products-header\">\n<h2 id=\"related-products-title\">Semax and Selank Research Listings<\/h2>\n<p>These are laboratory research listings related directly to the compounds reviewed on this page. Supplier availability is not evidence of clinical benefit, medicine approval, sterility or equivalence to published-study preparations.<\/p>\n<\/div>\n<div class=\"related-products-grid two-col\">\n<article class=\"related-product-card\">\n<div class=\"related-product-image-wrap\">\n<img data-recalc-dims=\"1\" alt=\"Semax 10mg and 30mg laboratory research listing\" class=\"related-product-image\" decoding=\"async\" height=\"600\" loading=\"lazy\" src=\"https:\/\/i0.wp.com\/balticpeptides.com\/wp-content\/uploads\/2026\/07\/SEMAX10VIAL-1-300x300.png?resize=600%2C600&#038;ssl=1\" width=\"600\"\/>\n<\/div>\n<div class=\"related-product-body\">\n<div class=\"related-product-tag\">Laboratory research listing<\/div>\n<h3>Semax (10mg \/ 30mg) \u2014 Vial \/ Nasal Spray<\/h3>\n<p class=\"related-product-note\">Related to the Semax evidence and FDA context discussed above.<\/p>\n<p class=\"related-product-price\">\u20ac34.99\u2013\u20ac59.99<\/p>\n<div class=\"related-product-actions\">\n<a class=\"related-product-btn primary\" data-affiliate-link=\"\" data-position=\"bottom-products\" data-product=\"semax\" href=\"https:\/\/balticpeptides.com\/product\/semax\/?sld=17\" rel=\"sponsored nofollow noopener\" target=\"_blank\">View Supplier Listing<\/a>\n<a class=\"related-product-btn secondary\" href=\"https:\/\/peptidedeepdive.com\/semax\/\">Read the Semax Guide<\/a>\n<\/div>\n<\/div>\n<\/article>\n<article class=\"related-product-card\">\n<div class=\"related-product-image-wrap\">\n<img data-recalc-dims=\"1\" alt=\"Selank 10mg laboratory research listing\" class=\"related-product-image\" decoding=\"async\" height=\"600\" loading=\"lazy\" src=\"https:\/\/i0.wp.com\/balticpeptides.com\/wp-content\/uploads\/2026\/07\/SELANK10VIAL-1-300x300.png?resize=600%2C600&#038;ssl=1\" width=\"600\"\/>\n<\/div>\n<div class=\"related-product-body\">\n<div class=\"related-product-tag\">Laboratory research listing<\/div>\n<h3>Selank (10mg) \u2014 Vial \/ Nasal Spray<\/h3>\n<p class=\"related-product-note\">Related to the Selank clinical and mechanistic evidence discussed above.<\/p>\n<p class=\"related-product-price\">\u20ac34.99\u2013\u20ac39.99<\/p>\n<div class=\"related-product-actions\">\n<a class=\"related-product-btn primary\" data-affiliate-link=\"\" data-position=\"bottom-products\" data-product=\"selank\" href=\"https:\/\/balticpeptides.com\/product\/selank\/?sld=17\" rel=\"sponsored nofollow noopener\" target=\"_blank\">View Supplier Listing<\/a>\n<a class=\"related-product-btn secondary\" href=\"https:\/\/peptidedeepdive.com\/selank\/\">Read the Selank Guide<\/a>\n<\/div>\n<\/div>\n<\/article>\n<\/div>\n<p class=\"related-products-disclosure\"><strong>Affiliate disclosure:<\/strong> Supplier links are affiliate links, so PeptideDeepDive may receive a commission. Prices reflect supplier data checked on 18 September 2026 and may change. Listings are for laboratory research only and are not medicines or recommendations for human use.<\/p>\n<\/section>\n<div class=\"refs\">\n<h3>References<\/h3>\n<ol>\n<li>Panikratova YR et al. (2020). <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32342318\/\" rel=\"noopener noreferrer\" target=\"_blank\"><em>Functional Connectomic Approach to Studying Selank and Semax Effects<\/em><\/a> \u2014 52 healthy participants in separate Semax, Selank and placebo groups.<\/li>\n<li>Zozulia AA et al. (2008). <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18454096\/\" rel=\"noopener noreferrer\" target=\"_blank\"><em>Efficacy and possible mechanisms of action of Selank in generalized anxiety disorders and neurasthenia<\/em><\/a> \u2014 62-patient comparison with medazepam.<\/li>\n<li>Semax clinical literature: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/11517472\/\" rel=\"noopener noreferrer\" target=\"_blank\">acute ischaemic stroke clinical study<\/a>; mechanistic background: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16996037\/\" rel=\"noopener noreferrer\" target=\"_blank\">BDNF\/TrkB animal research<\/a>.<\/li>\n<li>U.S. Food and Drug Administration (2026). <a href=\"https:\/\/www.fda.gov\/media\/193348\/download\" rel=\"noopener noreferrer\" target=\"_blank\">FDA briefing document for Semax-related bulk drug substances<\/a>; see also FDA&#8217;s <a href=\"https:\/\/www.fda.gov\/drugs\/human-drug-compounding\/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks\" rel=\"noopener noreferrer\" target=\"_blank\">current compounding safety summary<\/a> for Semax and Selank acetate.<\/li>\n<li>MHRA. <a href=\"https:\/\/www.gov.uk\/government\/publications\/supply-unlicensed-medicinal-products-specials\/supply-unlicensed-medicinal-products-specials\" rel=\"noopener noreferrer\" target=\"_blank\">Supply unlicensed medicinal products (\u201cspecials\u201d)<\/a>.<\/li>\n<li>Health Products Regulatory Authority, Ireland. <a href=\"https:\/\/www.hpra.ie\/regulation\/human-medicine\/wholesalers-and-retailers\/exempt-medicinal-products\" rel=\"noopener noreferrer\" target=\"_blank\">Exempt medicinal products<\/a>.<\/li>\n<li>German Federal Ministry of Justice. <a href=\"https:\/\/www.gesetze-im-internet.de\/englisch_amg\/englisch_amg.html\" rel=\"noopener noreferrer\" target=\"_blank\">Medicinal Products Act (Arzneimittelgesetz), including section 21<\/a>.<\/li>\n<li>European Union. <a href=\"https:\/\/eur-lex.europa.eu\/eli\/dir\/2001\/83\/2025-01-01\/eng\" rel=\"noopener noreferrer\" target=\"_blank\">Directive 2001\/83\/EC<\/a>, consolidated version applicable from 1 January 2025.<\/li>\n<\/ol>\n<\/div>\n<\/main>\n<footer>\n<div class=\"wrap\">\n<a aria-label=\"PeptideDeepDive home\" class=\"brand\" href=\"https:\/\/peptidedeepdive.com\/\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" alt=\"PeptideDeepDive logo\" class=\"brand-logo\" height=\"30\" src=\"https:\/\/i0.wp.com\/peptidedeepdive.com\/wp-content\/uploads\/2026\/07\/PeptideDeepDiveLogo-transparent.png?resize=30%2C30&#038;ssl=1\" width=\"30\"\/>PeptideDeepDive<\/a>\n<p>Educational content only. Not medical advice. Talk to a qualified healthcare provider before making decisions about your health.<\/p>\n<\/div>\n<\/footer>\n","protected":false},"excerpt":{"rendered":"<p>Semax vs Selank: Evidence, Differences &amp; Legal Status (2026) PeptideDeepDive Shop Research Lab Reports About FAQ Contact Home \/ Research \/ Semax vs Selank Guide \u00b7 Cognitive &amp; CNS Semax vs Selank: Evidence, Differences &amp; Legal Status (2026) Semax and Selank are often grouped together as Russian-origin cognitive peptides, but they have different structures, research <a href=\"https:\/\/peptidedeepdive.com\/nl\/semax-selank\/\" class=\"more-link\">&#8230;<span class=\"screen-reader-text\">  Semax &amp; Selank: Evidence, Legal Status &amp; How They Compare<\/span><\/a><\/p>","protected":false},"author":282947824,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_wpcom_ai_launchpad_about_page":false,"_wpcom_ai_launchpad_gallery_page":false,"_wpcom_ai_launchpad_contact_page":false,"_wpcom_ai_launchpad_events_page":false,"_wpcom_ai_launchpad_video_page":false,"_wpcom_ai_launchpad_portfolio_piece":false,"_zipai_imported":false,"footnotes":""},"class_list":["post-856","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.5 (Yoast SEO v28.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Semax vs Selank: Evidence, Differences &amp; Legal Status (2026)<\/title>\n<meta name=\"description\" content=\"Semax vs Selank compared: mechanisms, human evidence, a 52-person comparison study, FDA context and current UK\/EU legal status in 2026.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/peptidedeepdive.com\/nl\/semax-selank\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Semax &amp; Selank: Evidence, Legal Status &amp; How They Compare\" \/>\n<meta property=\"og:description\" content=\"Semax vs Selank compared: mechanisms, human evidence, a 52-person comparison study, FDA context and current UK\/EU legal status in 2026.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/peptidedeepdive.com\/nl\/semax-selank\/\" \/>\n<meta property=\"og:site_name\" content=\"PeptideDeepDive\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-22T13:25:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/peptidedeepdive.com\/wp-content\/uploads\/2026\/07\/PeptideDeepDiveLogo-transparent.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data1\" content=\"10 minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/peptidedeepdive.com\\\/semax-selank\\\/\",\"url\":\"https:\\\/\\\/peptidedeepdive.com\\\/semax-selank\\\/\",\"name\":\"Semax vs Selank: Evidence, Differences & Legal Status (2026)\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/peptidedeepdive.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/peptidedeepdive.com\\\/semax-selank\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/peptidedeepdive.com\\\/semax-selank\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/peptidedeepdive.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/PeptideDeepDiveLogo-transparent.png\",\"datePublished\":\"2026-08-09T04:21:00+00:00\",\"dateModified\":\"2026-09-22T13:25:52+00:00\",\"description\":\"Semax vs Selank compared: mechanisms, human evidence, a 52-person comparison study, FDA context and current UK\\\/EU legal status in 2026.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/peptidedeepdive.com\\\/semax-selank\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/peptidedeepdive.com\\\/semax-selank\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/peptidedeepdive.com\\\/semax-selank\\\/#primaryimage\",\"url\":\"https:\\\/\\\/peptidedeepdive.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/PeptideDeepDiveLogo-transparent.png\",\"contentUrl\":\"https:\\\/\\\/peptidedeepdive.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/PeptideDeepDiveLogo-transparent.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/peptidedeepdive.com\\\/semax-selank\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/peptidedeepdive.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Semax &amp; Selank: Evidence, Legal Status &amp; How They Compare\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/peptidedeepdive.com\\\/#website\",\"url\":\"https:\\\/\\\/peptidedeepdive.com\\\/\",\"name\":\"PeptidesExplained\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/peptidedeepdive.com\\\/#\\\/schema\\\/person\\\/8aa4df0c53d17a692e53269a6aeb62c2\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/peptidedeepdive.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/peptidedeepdive.com\\\/#\\\/schema\\\/person\\\/8aa4df0c53d17a692e53269a6aeb62c2\",\"name\":\"Laurynas Dabasinskas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/586f2b309850fb3714cfa847846917ddcd7734c751912dab6d133d17a26ba12d?s=96&d=identicon&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/586f2b309850fb3714cfa847846917ddcd7734c751912dab6d133d17a26ba12d?s=96&d=identicon&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/586f2b309850fb3714cfa847846917ddcd7734c751912dab6d133d17a26ba12d?s=96&d=identicon&r=g\",\"caption\":\"Laurynas Dabasinskas\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/586f2b309850fb3714cfa847846917ddcd7734c751912dab6d133d17a26ba12d?s=96&d=identicon&r=g\"},\"sameAs\":[\"http:\\\/\\\/ldabasinskas2003-fozpm.wordpress.com\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Semax vs Selank: Evidence, Differences & Legal Status (2026)","description":"Semax vs Selank compared: mechanisms, human evidence, a 52-person comparison study, FDA context and current UK\/EU legal status in 2026.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/peptidedeepdive.com\/nl\/semax-selank\/","og_locale":"nl_NL","og_type":"article","og_title":"Semax &amp; Selank: Evidence, Legal Status &amp; How They Compare","og_description":"Semax vs Selank compared: mechanisms, human evidence, a 52-person comparison study, FDA context and current UK\/EU legal status in 2026.","og_url":"https:\/\/peptidedeepdive.com\/nl\/semax-selank\/","og_site_name":"PeptideDeepDive","article_modified_time":"2026-09-22T13:25:52+00:00","og_image":[{"url":"https:\/\/peptidedeepdive.com\/wp-content\/uploads\/2026\/07\/PeptideDeepDiveLogo-transparent.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Geschatte leestijd":"10 minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/peptidedeepdive.com\/semax-selank\/","url":"https:\/\/peptidedeepdive.com\/semax-selank\/","name":"Semax vs Selank: Evidence, Differences & Legal Status (2026)","isPartOf":{"@id":"https:\/\/peptidedeepdive.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/peptidedeepdive.com\/semax-selank\/#primaryimage"},"image":{"@id":"https:\/\/peptidedeepdive.com\/semax-selank\/#primaryimage"},"thumbnailUrl":"https:\/\/peptidedeepdive.com\/wp-content\/uploads\/2026\/07\/PeptideDeepDiveLogo-transparent.png","datePublished":"2026-08-09T04:21:00+00:00","dateModified":"2026-09-22T13:25:52+00:00","description":"Semax vs Selank compared: mechanisms, human evidence, a 52-person comparison study, FDA context and current UK\/EU legal status in 2026.","breadcrumb":{"@id":"https:\/\/peptidedeepdive.com\/semax-selank\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/peptidedeepdive.com\/semax-selank\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/peptidedeepdive.com\/semax-selank\/#primaryimage","url":"https:\/\/peptidedeepdive.com\/wp-content\/uploads\/2026\/07\/PeptideDeepDiveLogo-transparent.png","contentUrl":"https:\/\/peptidedeepdive.com\/wp-content\/uploads\/2026\/07\/PeptideDeepDiveLogo-transparent.png"},{"@type":"BreadcrumbList","@id":"https:\/\/peptidedeepdive.com\/semax-selank\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/peptidedeepdive.com\/"},{"@type":"ListItem","position":2,"name":"Semax &amp; Selank: Evidence, Legal Status &amp; How They Compare"}]},{"@type":"WebSite","@id":"https:\/\/peptidedeepdive.com\/#website","url":"https:\/\/peptidedeepdive.com\/","name":"PeptidesExplained","description":"","publisher":{"@id":"https:\/\/peptidedeepdive.com\/#\/schema\/person\/8aa4df0c53d17a692e53269a6aeb62c2"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/peptidedeepdive.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":["Person","Organization"],"@id":"https:\/\/peptidedeepdive.com\/#\/schema\/person\/8aa4df0c53d17a692e53269a6aeb62c2","name":"Laurynas Dabasinskas","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/secure.gravatar.com\/avatar\/586f2b309850fb3714cfa847846917ddcd7734c751912dab6d133d17a26ba12d?s=96&d=identicon&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/586f2b309850fb3714cfa847846917ddcd7734c751912dab6d133d17a26ba12d?s=96&d=identicon&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/586f2b309850fb3714cfa847846917ddcd7734c751912dab6d133d17a26ba12d?s=96&d=identicon&r=g","caption":"Laurynas Dabasinskas"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/586f2b309850fb3714cfa847846917ddcd7734c751912dab6d133d17a26ba12d?s=96&d=identicon&r=g"},"sameAs":["http:\/\/ldabasinskas2003-fozpm.wordpress.com"]}]}},"spectra_blocks_featured_image_url":null,"spectra_blocks_author_info":{"display_name":"Laurynas Dabasinskas","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/586f2b309850fb3714cfa847846917ddcd7734c751912dab6d133d17a26ba12d?s=96&d=identicon&r=g","author_link":"https:\/\/peptidedeepdive.com\/nl\/author\/ldabasinskas2003\/","description":""},"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/PhlgTH-dO","jetpack-related-posts":[{"id":350,"url":"https:\/\/peptidedeepdive.com\/nl\/selank\/","url_meta":{"origin":856,"position":0},"title":"Selank","author":"Laurynas Dabasinskas","date":"juli 29, 2026","format":false,"excerpt":"What Is Selank? Anxiety Evidence & Nasal Spray Status (2026) PeptideDeepDive Shop Research Lab Reports About FAQ Contact Research \/ Individual Guides \/ Selank Peptide Guide \u00b7 Cognitive & Mood What Is Selank? Anxiety Evidence, Nasal Spray & Legal Status Selank is a Russian-developed heptapeptide studied mainly for anxiety-related effects\u2026","rel":"","context":"Soortgelijk bericht","block_context":{"text":"Soortgelijk bericht","link":""},"img":{"alt_text":"PeptideDeepDive logo","src":"https:\/\/i0.wp.com\/peptidedeepdive.com\/wp-content\/uploads\/2026\/07\/PeptideDeepDiveLogo-transparent.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":347,"url":"https:\/\/peptidedeepdive.com\/nl\/semax\/","url_meta":{"origin":856,"position":1},"title":"What Is Semax?","author":"Laurynas Dabasinskas","date":"juli 29, 2026","format":false,"excerpt":"What Is Semax? Evidence, Uses & FDA Status (2026) PeptideDeepDive Shop Research Lab Reports About FAQ Contact Research \/ Individual Guides \/ Semax Guide \u00b7 Cognitive & Mood What Is Semax? Evidence, Uses & FDA Status Semax is a synthetic ACTH-derived heptapeptide used as an intranasal prescription medicine in Russia\u2026","rel":"","context":"Soortgelijk bericht","block_context":{"text":"Soortgelijk bericht","link":""},"img":{"alt_text":"PeptideDeepDive logo","src":"https:\/\/i0.wp.com\/peptidedeepdive.com\/wp-content\/uploads\/2026\/07\/PeptideDeepDiveLogo-transparent.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":442,"url":"https:\/\/peptidedeepdive.com\/nl\/ultimate-cognitive-stack\/","url_meta":{"origin":856,"position":2},"title":"Semax + Selank Stack: Evidence, Safety &amp; the Unstudied Combination","author":"Laurynas Dabasinskas","date":"juli 29, 2026","format":false,"excerpt":"Semax and Selank Stack: Evidence, Safety & Risks (2026) PeptideDeepDive Shop Research Lab Reports About FAQ Contact Research \/ Safety & Risk \/ Semax + Selank Combination Safety \u00b7 Cognitive & mood Semax and Selank Stack: Evidence, Safety & Risks Semax and Selank are often marketed together as a cognitive\u2026","rel":"","context":"Soortgelijk bericht","block_context":{"text":"Soortgelijk bericht","link":""},"img":{"alt_text":"Two nasal-spray bottles representing the Semax and Selank combination","src":"https:\/\/i0.wp.com\/d8j0ntlcm91z4.cloudfront.net\/user_3GYMvT1tR5HC1gvee5MuSPX1OIk\/hf_20260820_221620_7283de4b-5b58-4d65-84c7-46ba34f59f03.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/d8j0ntlcm91z4.cloudfront.net\/user_3GYMvT1tR5HC1gvee5MuSPX1OIk\/hf_20260820_221620_7283de4b-5b58-4d65-84c7-46ba34f59f03.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/d8j0ntlcm91z4.cloudfront.net\/user_3GYMvT1tR5HC1gvee5MuSPX1OIk\/hf_20260820_221620_7283de4b-5b58-4d65-84c7-46ba34f59f03.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/d8j0ntlcm91z4.cloudfront.net\/user_3GYMvT1tR5HC1gvee5MuSPX1OIk\/hf_20260820_221620_7283de4b-5b58-4d65-84c7-46ba34f59f03.png?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":829,"url":"https:\/\/peptidedeepdive.com\/nl\/peptides-compared\/","url_meta":{"origin":856,"position":3},"title":"7 Research Peptides Compared: BPC-157, TB-500, GHK-Cu &amp; More","author":"Laurynas Dabasinskas","date":"augustus 8, 2026","format":false,"excerpt":"Recovery Peptides Compared: BPC-157 vs TB-500 (2026) PeptideDeepDive Shop Research Lab Reports About FAQ Contact Research \/ Comparisons \/ Recovery Peptides Compared Guide \u00b7 Comparison Recovery Peptides Compared: BPC-157, TB-500 & More (2026) Compare BPC-157, TB-500, GHK-Cu, KPV and MOTS-c by human evidence, safety gaps and UK\/EU medicine status. The\u2026","rel":"","context":"Soortgelijk bericht","block_context":{"text":"Soortgelijk bericht","link":""},"img":{"alt_text":"PeptideDeepDive logo","src":"https:\/\/i0.wp.com\/peptidedeepdive.com\/wp-content\/uploads\/2026\/07\/PeptideDeepDiveLogo-transparent.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":323,"url":"https:\/\/peptidedeepdive.com\/nl\/research\/","url_meta":{"origin":856,"position":4},"title":"Onderzoek","author":"Laurynas Dabasinskas","date":"juli 29, 2026","format":false,"excerpt":"Peptide Research Guides & Supplier Comparisons | Europe PeptideDeepDive Shop Research Lab Reports About FAQ Contact Research Peptide Research Guides, Comparisons & Evidence Evidence-focused peptide research guides covering mechanisms, human data, legal status, comparisons and documented safety questions. 11Individual Guides 8Comparisons 3Research Summaries 5Safety & Risk Articles 4European Supplier Guides\u2026","rel":"","context":"Soortgelijk bericht","block_context":{"text":"Soortgelijk bericht","link":""},"img":{"alt_text":"PeptideDeepDive logo","src":"https:\/\/i0.wp.com\/peptidedeepdive.com\/wp-content\/uploads\/2026\/07\/PeptideDeepDiveLogo-transparent.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":1383,"url":"https:\/\/peptidedeepdive.com\/nl\/semax-europe-suppliers\/","url_meta":{"origin":856,"position":5},"title":"Semax Suppliers in Europe: Vials, Sprays and COAs Compared","author":"Laurynas Dabasinskas","date":"september 17, 2026","format":false,"excerpt":"Semax Suppliers in Europe: 3 Compared (2026) PeptideDeepDive Shop Research Lab Reports About FAQ Contact Shop Research Lab Reports About FAQ Home \/ Research \/ Semax Europe suppliers Supplier comparison \u00b7 Semax Europe Semax Suppliers in Europe: 3 Compared (2026) This comparison examines Semax suppliers in Europe by vial and\u2026","rel":"","context":"Soortgelijk bericht","block_context":{"text":"Soortgelijk bericht","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/peptidedeepdive.com\/wp-content\/uploads\/2026\/07\/PeptideDeepDiveLogo-transparent.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]}],"_links":{"self":[{"href":"https:\/\/peptidedeepdive.com\/nl\/wp-json\/wp\/v2\/pages\/856","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/peptidedeepdive.com\/nl\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/peptidedeepdive.com\/nl\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/peptidedeepdive.com\/nl\/wp-json\/wp\/v2\/users\/282947824"}],"replies":[{"embeddable":true,"href":"https:\/\/peptidedeepdive.com\/nl\/wp-json\/wp\/v2\/comments?post=856"}],"version-history":[{"count":7,"href":"https:\/\/peptidedeepdive.com\/nl\/wp-json\/wp\/v2\/pages\/856\/revisions"}],"predecessor-version":[{"id":1521,"href":"https:\/\/peptidedeepdive.com\/nl\/wp-json\/wp\/v2\/pages\/856\/revisions\/1521"}],"wp:attachment":[{"href":"https:\/\/peptidedeepdive.com\/nl\/wp-json\/wp\/v2\/media?parent=856"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}